News & Announcements
-
Half-year Report
/**/ RNS Number : 5460J IQ-AI Limited 17 August 2023 17 August 2023 IQ-AI Limited (the “Company” or the “Group”) Half Yearly Report for the Period Ended 30 June 2023 The Board of IQ-AI Ltd is pleased to announce the Company’s half yearly report for the period ended 30 June 2023. For further information,…
-
Orphan Drug Designation for GaM in Pediatric GBM
/**/ RNS Number : 8411F IQ-AI Limited 13 July 2023 13 July 2023 IQ-AI Ltd (“IQ-AI” or the “Company”) Orphan Drug Designation for GaM in Pediatric GBM Imaging Biometrics, LLC (IB), a wholly-owned subsidiary of IQ-AI Ltd (LSE: IQAI, OTCQB: IQAIF), today announced the U.S. Food and Drug Administration (US FDA) has…
-
Result of AGM
/**/ RNS Number : 3655A IQ-AI Limited 23 May 2023 IQ-AI Limited (“IQ-AI” or the “Company”) Result of AGM IQ-AI Limited announces that at the annual general meeting of the Company held earlier today, all resolutions were duly passed. The Directors of the Company accept responsibility for the contents of…
-
AGM Statement
/**/ RNS Number : 2406A IQ-AI Limited 23 May 2023 IQ-AI Limited (“IQ-AI” or the “Company”) AGM Statement IQ-AI Limited is due to hold its AGM today. At the AGM, the Chairman will announce the following: • Over 200 more datasets have been received in collaboration with Phoenix Children’s Hospital.…
-
Notice of AGM
/**/ RNS Number : 3203Y IQ-AI Limited 03 May 2023 IQ-AI Ltd (“IQ-AI” or the “Company”) Notice of AGM IQ-AI Limited announces that notice of the annual general meeting of the Company, to be held at Third Floor, Forum 4, Grenville Street, St Helier, Jersey, JE2 4UF on 23 May 2023…